Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.
- DOI
- 10.7554/elife.87030
- Published
- 2024 Jul 16
- Container
- eLife
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.7554/elife.87030,
title = {Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.},
author = {Porter JC and Inshaw J and Solis VJ and Denneny E and Evans R and Temkin MI and De Vasconcelos N and Aramburu IV and Hoving D and Basire D and Crissell T and Guinto J and Webb A and Esmail H and Johnston V and Last A and Rampling T and Lippert L and Helbig ET and Kurth F and Williams B and Flynn A and Lukey PT and Birault V and Papayannopoulos V},
year = {2024},
journal = {eLife},
doi = {10.7554/elife.87030},
url = {https://doi.org/10.7554/elife.87030}
}RIS
TY - JOUR TI - Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial. AU - Porter JC AU - Inshaw J AU - Solis VJ AU - Denneny E AU - Evans R AU - Temkin MI AU - De Vasconcelos N AU - Aramburu IV AU - Hoving D AU - Basire D AU - Crissell T AU - Guinto J AU - Webb A AU - Esmail H AU - Johnston V AU - Last A AU - Rampling T AU - Lippert L AU - Helbig ET AU - Kurth F AU - Williams B AU - Flynn A AU - Lukey PT AU - Birault V AU - Papayannopoulos V PY - 2024 JO - eLife DO - 10.7554/elife.87030 UR - https://doi.org/10.7554/elife.87030 ER -
APA
JC, P., J, I., VJ, S., E, D., R, E., MI, T., N, D. V., IV, A., D, H., D, B., T, C., J, G., A, W., H, E., V, J., A, L., T, R., L, L., ET, H., F, K., B, W., A, F., PT, L., V, B., & V, P. (2024). Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.. eLife. https://doi.org/10.7554/elife.87030
Source records
- pubmed · retrieved 2026-09-26T23:39:42.354Z